Results

Total Results: 60 records

Showing results for "neoplasms malignant neoplasm".

41. breast-biopsy-update-130920 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_research-protocol.pdf
    September 20, 2013 - is the second most common malignancy (after skin cancer), and the second most common cause of cancer … performance outcomes, as assessed by the following measures:  Sensitivity (proportion of cancerous tumors … Cosmetic results □ Quality of life □ Anxiety and other psychological outcomes □ Time to complete tumor … /di or exp breast neoplasms/di or exp breast disease/di or exp breast diseases/di 4 (breast or … or$ or lesion$ or cancer or carcinoma$ or lump$) 5 Combine sets or/2-4 6 Biopsy 5 and ((Biopsy or tumor

42. Future Research Needs Document (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - and the most aggressive breast cancers. … Population- based estimates of the relation between breast cancer risk, tumor subtype, and family history … Reactivation of Tumor Suppressor Genes in Breast Cancer by Dietary Supplements As. 2009. 178. 5F32AT004876 … Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature … /ep, et 10531 8 4 and 7 1164 9 exp breast neoplasms/pc, eh 7858 10 exp breast neoplasms/ge 18582

43. Cell-Free-Dna-Appendix-C-Prepub-Final (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
    January 01, 2025 - Neoplasia. 2023 Dec;46:100941. doi: 10.1016/j.neo.2023.100941. PMID: 37918207. … Validation cohort ("V") included 82 participants with GI cancers, 11 participants with benign tumors, … The diagnostic performance of the tumor markers for GI cancer screening (analysis 1) and whole-body cancer … Staging per TNM Classification of Malignant Tumors by Union for International Cancer Control, 8th ed. … Both new and recurrent: 1/35 Solid tumors: 19/35 (53%) Hematologic: 17/35 (47%) TP with new cancer:

44. Cell-Free-Dna-Final-App-C (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
    January 01, 2025 - Neoplasia. 2023 Dec;46:100941. doi: 10.1016/j.neo.2023.100941. PMID: 37918207. … Validation cohort ("V") included 82 participants with GI cancers, 11 participants with benign tumors, … The diagnostic performance of the tumor markers for GI cancer screening (analysis 1) and whole-body cancer … Staging per TNM Classification of Malignant Tumors by Union for International Cancer Control, 8th ed. … Both new and recurrent: 1/35 Solid tumors: 19/35 (53%) Hematologic: 17/35 (47%) TP with new cancer:

45. Stroke Prevention in Atr ial Fibr illation Patients: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
    October 27, 2017 - 65), drugs/alcohol concomitantly; HEMORR2HAGES = hepatic or renal disease, ethanol (alcohol) abuse, malignancy … 65), drugs/alcohol concomitantly HEMORR2HAGES hepatic or renal disease, ethanol (alcohol) abuse, malignancy … Chronic"[Mesh] OR "Diabetes Mellitus"[Mesh] OR "Sex Factors"[Mesh] OR "Population Groups"[Mesh] OR "Neoplasms … [tiab] OR cancers[tiab] OR tumor[tiab] OR tumors[tiab] OR tumours[tiab] OR tumour[tiab] OR carcinoma … [tiab] OR carcinomas[tiab] OR neoplasm[tiab] or neoplasms[tiab] OR HIV[tiab] OR "human immunodeficiency

46. Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
    December 16, 2014 - PIVOT conducted in the US and primarily involved men with PSA detected tumors. … Nearly 80% of SPCG-4 subjects had T2 (palpable) tumors vs. only about 45% in PIVOT. P 59. … The report focuses only on T1 through T3a cancers. … , Reduces the risk of a second malignant neoplasms (SMN) in prostate patients compared with contemporary … Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x- ray therapy for

47. Breast-Cancer-Imaging Technical-Brief (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
    October 01, 2014 - inclusion criteria • Tumor factors (e.g., whether metastatic tumors were initially diagnosed or were … to detect tumors on PET imaging. … compared with PET/CTs for other solid organ malignancies, such that even at major cancer centers in … Neoplasia. 2008 May;10(5):511-20. PMID: 18472968. … Photodynamic therapy with verteporfin of choroidal malignancy from breast cancer.

48. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
    January 10, 2012 - cell-directed therapy suggest an immunologic nature of the disease. 8,9 Various cytokines, like tumor … We have not listed specific malignancies (hepatosplenic T-cell lymphoma and other lymphomas) and infections … of first- line therapy including full-dose nonsteroidal anti-inflammatory agents; trophoblastic neoplasms … for this indication Cyclophos- phamide‡ Cytoxan ® (injectable) Baxter Healthcare Treatment of malignancies … parameters (e.g. glucose, lipids, weight, BMI, thyroid function)  Injection site reaction  Malignancy

49. Breast Abnormalities Update Surveillance Assessment_CER 47_Low (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_surveillance.pdf
    September 01, 2012 - Gokalp and Topal 24 ); however, only one enrolled patient (out of 43 total) was found to have a malignancy … COVERED: MEDLINE ON OVID – 1/1/2010-8/27/2012 LANGUAGE: English SEARCH STRATEGY: exp Breast neoplasms … / or exp breast diseases/ or exp breast cancer/ or breast carcinoma/ or ((breast or mammary) and (cancer … $ or neoplasm$ or carcinoma$ or tumor$ or tumour$ or lump$ or lesion$)).mp. … (Gokalp and Topal 24 ); however, only one enrolled patient (out of 43 total) was found to have a malignancy

50. Comparative Effectiveness of β-Adrenergic Antagonists on the Risk of Rehospitalization in Adults with Heart Failure (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
    November 01, 2007 - Based on outpatient or inpatient claim for cancer or cancer-related care using the following ICD- … 9 codes: ICD-9-CM Codes Diagnosis (in preferred ICD-O-3 terminology) 140.0 - 208.9 Malignant neoplasms … 9733/3) 205.1 Chronic neutrophilic leukemia (9963/3) 230.0 - 234.9 Carcinoma in situ 235.0 - 238.9 Neoplasms … Cost of care for patients in cancer clinical trials. … J Natl Cancer Inst 2000;92(2):136-42.

51. Evidence-based Practice Center Technical Brief Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/pain-chronic_research-protocol.pdf
    July 28, 2010 - Brief Protocol Project Title: Technical Brief - Multidisciplinary Pain Programs for Chronic Non-Cancer … Background and Objectives for the Technical Brief Chronic non-cancer pain: Chronic pain symptoms … estimates that 9 percent of the United States adult population suffers from moderate to severe, non-cancer … Patients with cancer 2. … Published Online: July 28, 2010 12 21 "pain clinic".tw. 22 19 or 20 or 21 23 18 or 22 24 exp Neoplasms

52. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/genitourinary-symptoms-protocol_0.pdf
    July 10, 2023 - cancers, a high risk of cancer, or conditions such as primary ovarian insufficiency, women experiencing … misdiagnosis as another condition with similar presentation such as inflammatory dermatologic conditions, malignancy … , breast cancer recurrence or progression, breast tenderness, cardiovascular risk, endometrial cancer … The Use of Vaginal Estrogen in Women With a History of Estrogen- Dependent Breast Cancer. … rabbits or rat or rats).ti,ab. 3287242 18 Penile Erection/ or Erectile Dysfunction/ or Prostatic Neoplasms

53. Liver-Cancer Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
    October 01, 2014 - Executive Summary Background and Objectives Hepatocellular carcinoma (HCC) is the most common primary malignant … neoplasm of the liver, usually developing in individuals with chronic liver disease or cirrhosis. … Worldwide, it is the fifth most common cancer and the third most common cause of cancer death.1 There … National Cancer Institute. Liver Cancer. www.cancer.gov/ cancertopics/types/liver. … SEER Cancer Statistics Review, 1975-2010.

54. Glaucoma-Treatment Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
    January 01, 2013 - Of 19,940 cases in the global safety database, 22 reports of ocular/cutaneous neoplasms were obtained … Of 19,940 cases in the global safety database, 22 reports of ocular/cutaneous neoplasms were obtained

55. CER 217 Management of Infertility Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
    May 01, 2019 - • Women who undergo IVF demonstrated an increased risk of ovarian neoplasms and colorectal malignancies … There is no evidence of a difference in invasive ovarian cancers (low SOE). … IVF was associated with a statistically significant increased risk of all ovarian neoplasms and borderline … ovarian tumors, and colorectal cancer No difference: IVF however was not associated with an increased … Effects of fertility drugs on cancers other than breast and gynecologic malignancies.

56. Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-evidence-summary.pdf
    January 01, 2020 - Past obstetric history and risk of malignant breast neoplasms. … Reproductive behaviors and risk of developing breast cancer according to tumor subtype: a systematic … Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between … Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. … Epidemiologic study of malignancies of the ovaries. Cancer. 1966 Jul;19(7):1001-7.

57. Association Between Outcomes and Dental Services in People Receiving Treatments That Cause Medication-Related Osteonecrosis of the Jaw: A Rapid Response Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-jaw-rapid-response.pdf
    May 01, 2025 - bone diseases, such as osteoporosis, Paget’s disease, and osteogenesis imperfecta, and metastatic cancers … If presented data included both cancer and non-cancer patients, studies were included if non-cancer subgroup … antiangiogenic agents, which are often prescribed to treat osteoclastic bone diseases, metastatic cancers … ") OR MJMESH.EXACT.EXPLODE("Mouth Neoplasms") OR TI,AB,IF,SU((oral OR mouth) N/2 (cancer* OR carcino … s OR neoplasm* OR malignan* OR tumo$r*))) 1143 10 S9 AND (TI,AB,SU,DTYPE(case-control OR ((cohort

58. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
    January 30, 2020 - Effect of methotrexate, anti-tumor necrosis factor alpha, and rituximab on the immune response to influenza … Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy … [Clinical efficacy and relative factors of dendritic cell-based tumor vaccination for prostate cancer … CTEP Cancer Therapy Evaluation Program: Common Terminology Criteria for Adverse Events (CTCAE) March … Investigations • Metabolism and nutrition disorders • Musculoskeletal and connective tissue disorders • Neoplasms

59. Disposition of Comments Report for Technical Brief 14 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
    March 18, 2014 - diagnosis stage 0 or 1 disease, thanks to early detection, and have a very low risk of recurrence, second neoplasms … The Sisler article includes patients who may not have been cancer-free, had recurrence, or new cancers … Cancer type seems to be a critical predictor of what care is available – perhaps cancers with large … For multiple stages, does NA mean hematologic malignancies? … in the adult survivor of adult cancers.

60. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
    March 01, 2013 - , prostatitis, interstitial cystitis, urinary tract obstruction, urethral diverticulum, bladder tumor … , bladder stone, prostate cancer were excluded, as were those who had delivered a baby or undergone … , and interstitial cystitis; prostate specific antigen level greater than 4 ng/mL, prostate cancer … trial; serious illnesses or conditions which would preclude participation in any clinical trial (malignant … neoplasms, alcoholism, drug misuse); pregnancy or lactation; participation in any other study.